{"gene":"ASCC3","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2011,"finding":"ASCC3 is the largest subunit of the Activating Signal Cointegrator Complex (ASCC) and encodes a 3'-5' DNA helicase whose unwinding activity generates single-stranded DNA upon which the demethylase ALKBH3 preferentially acts to repair N-alkylated nucleotides (3-methylcytosine and 1-methyladenine). Loss of ASCC3 leads to increased 3-methylcytosine, reduced cancer cell proliferation, and formation of pH2A.X and 53BP1 foci, indicating a role in maintaining genomic integrity.","method":"Affinity purification of ALKBH3 complex, in vitro helicase assay, siRNA knockdown with alkylation damage resistance assays, immunofluorescence for DNA damage markers","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro helicase activity demonstrated, complex purified, multiple functional readouts with KD, replicated across cell lines","pmids":["22055184"],"is_preprint":false},{"year":2020,"finding":"The ASCC3 subunit functions as a dual-cassette Ski2-like nucleic acid helicase. The ASCC2-ASCC3 interaction interface was structurally characterized: the ASCC3 fragment comprises a central helical domain and terminal extended arms that clasp the compact ASCC2 unit. This interface is evolutionarily conserved and harbors numerous somatic cancer mutation sites; cancer-associated mutations reduce ASCC2-ASCC3 binding affinity. ASCC3 domain organization is similar to that of the spliceosomal RNA helicase Brr2.","method":"X-ray crystallography of ASCC2-ASCC3 interacting regions, binding affinity quantification, mutational analysis of cancer variants","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional mutagenesis and quantitative binding measurements in a single study","pmids":["33139697"],"is_preprint":false},{"year":2021,"finding":"ASCC3 promotes disassembly of collided ribosomes as part of the ribosome quality control (RQC) trigger complex. ASCC3-deficient cells display delayed removal of MMS-induced 1-methyladenosine (m1A) and 3-methylcytosine (m3C) from mRNA and impaired formation of MMS-induced P-bodies. ASCC3 also shows increased mRNA binding after MMS treatment, and its role in ribosome disassembly is proposed to allow access of ALKBH3 for demethylation of aberrant mRNA methylbases.","method":"Quantitative SILAC mass spectrometry of mRNA-binding proteome, ASCC3 knockdown with quantitative measurement of mRNA methylbases, P-body formation assay by immunofluorescence","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in a single study; functional phenotype in KD cells with quantitative readouts","pmids":["34217309"],"is_preprint":false},{"year":2021,"finding":"Biallelic loss-of-function variants in ASCC3 cause a neuromuscular syndrome in humans ranging from severe developmental delay to muscle fatigue, establishing ASCC3 as a disease gene. Genotype-phenotype correlation was observed: homozygous missense variants cause milder phenotypes, while compound heterozygotes for missense and presumed LOF variants are more severely affected, and no biallelic presumed LOF individuals are found, suggesting this genotype may be lethal.","method":"Exome/genome sequencing of seven unrelated families, clinical phenotyping, gnomAD population analysis","journal":"HGG advances","confidence":"Medium","confidence_rationale":"Tier 2 — human genetic evidence across multiple unrelated families with genotype-phenotype correlation, though no in vitro mechanistic follow-up","pmids":["35047834"],"is_preprint":false},{"year":2023,"finding":"ASCC3 stabilizes STAT3 signaling by recruiting CAND1, which inhibits ubiquitin-mediated proteasomal degradation of STAT3, thereby impairing the type I interferon response in non-small cell lung cancer cells and promoting immunosuppression. ASCC3 overexpression decreases CD8+ T cells, NK cells and dendritic cells and increases regulatory T cells in the tumor microenvironment.","method":"Immunoprecipitation, mass spectrometry, RNA sequencing, immunofluorescence, flow cytometry, in vivo mouse tumor models with ASCC3 knockdown and anti-PD-1 combination","journal":"Journal for immunotherapy of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP/MS identification of CAND1 interaction, functional KD with defined immune phenotype readouts in vitro and in vivo","pmids":["38148115"],"is_preprint":false},{"year":2025,"finding":"ASCC3 is recruited to stalled replication forks by its binding partner ASCC2, whose fork recruitment requires ubiquitin-binding activity and polyubiquitylation of PCNA at K164 by E3 ligases SHPRH, HLTF, and RFWD3. Upon replication stress, ASCC3 helicase activity unwinds DNA at stalled forks, remodeling gap-containing fork substrates and promoting fork reversal. ASCC3 also interacts with RPA and stimulates RPA accumulation on ssDNA to promote ATR activation, antagonizes RAD51-mediated recombination, and prevents chromosome breaks/gaps and mis-segregation.","method":"In vitro DNA unwinding/fork remodeling assays, co-immunoprecipitation, iPOND (isolation of proteins on nascent DNA), genetic epistasis with SHPRH/HLTF/RFWD3/BRCA1/BRCA2, RPA accumulation assays, ATR activation assays, chromosome break quantification","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution of fork remodeling activity, multiple orthogonal genetic and biochemical approaches, strong mechanistic dissection","pmids":["41785087"],"is_preprint":false},{"year":2025,"finding":"FMRP (fragile X messenger ribonucleoprotein) regulates collided ribosomes by recruiting ASCC3 to collided ribosomes. Loss of FMRP reduces ASCC3 abundance. ASCC3 overexpression in fetal Fmr1 KO mouse brains promotes neuronal migration, and CRISPR-mediated activation of ASCC3 via AAV injection ameliorates synaptic defects, locomotor, cognitive, obsessive-compulsive-like, and social interaction deficits in Fmr1 KO mice. Disease-associated ASCC3 variants that disrupt ASCC3-FMRP interaction are also defective in ribosome association and handling of collided ribosomes.","method":"Co-immunoprecipitation of ASCC3-FMRP, ribosome association assays in cell lines and iPSC-derived neurons, Fmr1 KO mouse model with ASCC3 overexpression or CRISPRa-AAV, behavioral testing, mutagenesis of disease-associated variants","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (Co-IP, ribosome assays, mutagenesis, in vivo AAV rescue in mouse model) with defined functional phenotypes","pmids":["41061044"],"is_preprint":false},{"year":2024,"finding":"ASCC3, as a key factor for ribosome rescue, suppresses ribosome collisions that arise constitutively at UUA sense codons due to transient eRF1 misreading. Depletion of ASCC3 leads to accumulation of disomes at UUA codons and triggers stress responses including induction of the stress transcription factor ATF3, indicating ASCC3 is required for translation homeostasis.","method":"Disome-Seq (ribosome profiling of collided ribosomes) with ASCC3 depletion, stress response gene expression analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — ribosome profiling with ASCC3 KD provides direct mechanistic evidence; preprint, single lab","pmids":["bio_10.1101_2024.09.01.610654"],"is_preprint":true}],"current_model":"ASCC3 is a multifunctional Ski2-like 3'-5' DNA/RNA helicase that (1) generates single-stranded DNA to enable ALKBH3-mediated repair of N-alkylated nucleotides in a complex with ASCC2 (which anchors it to stalled replication forks via PCNA polyubiquitylation), (2) promotes fork reversal, RPA loading, and ATR activation at stalled replication forks while antagonizing RAD51 recombination, (3) disassembles collided ribosomes as part of the ribosome-associated quality control trigger complex to allow ALKBH3-mediated mRNA demethylation and to maintain translation homeostasis, (4) is recruited to collided ribosomes by FMRP to regulate neurodevelopmental translation, and (5) stabilizes STAT3 via CAND1 recruitment to inhibit its ubiquitin-mediated degradation in cancer cells."},"narrative":{"teleology":[{"year":2011,"claim":"Discovery that ASCC3 is a 3′-to-5′ DNA helicase within the ALKBH3 complex resolved how single-stranded DNA is generated for alkylation damage repair, establishing ASCC3's first known enzymatic activity and linking it to genomic integrity.","evidence":"Affinity purification of ALKBH3 complex, in vitro helicase assay, siRNA knockdown with alkylation sensitivity and DNA damage marker readouts in human cancer cell lines","pmids":["22055184"],"confidence":"High","gaps":["Structural basis of helicase activity and substrate specificity not resolved","How ASCC3 is recruited to sites of alkylation damage was unknown","Whether ASCC3 acts on RNA substrates in vivo was not addressed"]},{"year":2020,"claim":"Structural determination of the ASCC2-ASCC3 interface revealed a conserved dual-cassette Ski2-like helicase architecture and showed that somatic cancer mutations cluster at the binding surface, explaining how the complex is assembled and why certain cancer variants are loss-of-function.","evidence":"X-ray crystallography of ASCC2-ASCC3 interacting regions, quantitative binding assays, cancer variant mutagenesis","pmids":["33139697"],"confidence":"High","gaps":["Full-length ASCC3 structure and mechanism of helicase processivity not determined","How ASCC2-ASCC3 disruption by cancer mutations affects repair in cells was not tested","No structure of ASCC3 bound to nucleic acid substrates"]},{"year":2021,"claim":"Two parallel advances linked ASCC3 to ribosome quality control and human disease: ASCC3 was shown to disassemble collided ribosomes to allow ALKBH3-mediated mRNA demethylation, while independent genetic studies identified biallelic ASCC3 variants as causative for a neuromuscular syndrome with genotype-severity correlation.","evidence":"SILAC proteomics of mRNA-binding proteins after MMS, quantitative mRNA methylbase measurement, P-body assays (ribosome role); exome/genome sequencing across seven unrelated families with clinical phenotyping (disease genetics)","pmids":["34217309","35047834"],"confidence":"Medium","gaps":["Mechanism by which ASCC3 disassembles collided ribosomes was not reconstituted in vitro","No functional assay linking patient variants to helicase activity or ribosome disassembly defects at this stage","How mRNA demethylation defects contribute to neuromuscular pathology was unknown"]},{"year":2023,"claim":"An unexpected signaling role was uncovered: ASCC3 stabilizes STAT3 by recruiting CAND1 to inhibit ubiquitin-mediated STAT3 degradation, suppressing type I interferon signaling and promoting immunosuppression in non-small cell lung cancer.","evidence":"Reciprocal Co-IP/mass spectrometry for CAND1 interaction, RNA-seq, flow cytometry for immune cell populations, in vivo mouse tumor models with ASCC3 knockdown and anti-PD-1 combination","pmids":["38148115"],"confidence":"Medium","gaps":["Whether STAT3 stabilization depends on ASCC3 helicase activity or is independent was not tested","Generalizability to other cancer types not established","Mechanism by which ASCC3-CAND1 interaction blocks STAT3 ubiquitylation is unclear"]},{"year":2025,"claim":"Two studies completed the mechanistic picture at replication forks and collided ribosomes: ASCC3 was shown to be recruited to stalled forks via ASCC2/polyubiquitylated-PCNA to drive fork reversal, RPA loading, and ATR activation while antagonizing RAD51 recombination; separately, FMRP was identified as the factor that recruits ASCC3 to collided ribosomes, with disease-associated ASCC3 variants disrupting FMRP binding and ribosome association, and ASCC3 restoration rescuing Fragile X phenotypes in Fmr1 KO mice.","evidence":"In vitro fork remodeling and DNA unwinding, iPOND, genetic epistasis with SHPRH/HLTF/RFWD3/BRCA pathway (fork role); Co-IP of ASCC3-FMRP, ribosome profiling in iPSC-neurons, CRISPRa-AAV rescue of behavioral deficits in Fmr1 KO mice, disease variant mutagenesis (ribosome role)","pmids":["41785087","41061044"],"confidence":"High","gaps":["Whether the fork remodeling and ribosome QC functions are coordinated or independently regulated is unknown","Structural basis of ASCC3 engagement with collided ribosomes or reversed forks not resolved","Whether ASCC3-mediated fork reversal operates in normal replication or only under replication stress is unclear"]},{"year":null,"claim":"Key unresolved questions include how ASCC3's helicase activity is regulated to switch between DNA repair, replication fork protection, and ribosome quality control functions, whether the STAT3-stabilizing role depends on the same protein interfaces as its canonical repair/QC roles, and what structural basis underlies ASCC3's engagement with diverse nucleoprotein substrates.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length structure of ASCC3 or ASCC3-substrate complex available","Regulatory logic governing substrate-specific engagement (DNA forks vs. collided ribosomes) not defined","Contribution of each ASCC3 function to the human neuromuscular phenotype remains unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,5]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[2]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,5]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[5]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[2,6,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[5]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,6,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4]}],"complexes":["ASCC (Activating Signal Cointegrator Complex)","RQC trigger complex (ribosome quality control)"],"partners":["ASCC2","ALKBH3","FMRP","RPA","CAND1","STAT3","PCNA"],"other_free_text":[]},"mechanistic_narrative":"ASCC3 is a Ski2-like 3′-to-5′ DNA/RNA helicase that serves as the catalytic engine of the Activating Signal Cointegrator Complex, coupling nucleic acid unwinding to alkylation damage repair, replication fork protection, and ribosome-associated quality control. As the largest ASCC subunit, ASCC3 generates single-stranded DNA substrates for the demethylase ALKBH3 to remove 1-methyladenine and 3-methylcytosine lesions, and it is recruited to stalled replication forks via ASCC2-mediated recognition of polyubiquitylated PCNA, where its helicase activity promotes fork reversal, RPA loading, ATR activation, and suppression of RAD51-dependent recombination [PMID:22055184, PMID:41785087]. ASCC3 also disassembles collided ribosomes—recruited by FMRP—to maintain translational homeostasis and permit ALKBH3-mediated mRNA demethylation; loss of this function triggers stress responses and ribosome collision accumulation at UUA sense codons [PMID:34217309, PMID:41061044]. Biallelic loss-of-function variants in ASCC3 cause a human neuromuscular syndrome with developmental delay, and disease-associated missense variants disrupt FMRP interaction and ribosome association [PMID:35047834, PMID:41061044]."},"prefetch_data":{"uniprot":{"accession":"Q8N3C0","full_name":"Activating signal cointegrator 1 complex subunit 3","aliases":["ASC-1 complex subunit p200","ASC1p200","Helicase, ATP binding 1","Trip4 complex subunit p200"],"length_aa":2202,"mass_kda":251.5,"function":"ATPase involved both in DNA repair and rescue of stalled ribosomes (PubMed:22055184, PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). 3'-5' DNA helicase involved in repair of alkylated DNA: promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3, enabling ALKBH3 to process alkylated N3-methylcytosine (3mC) within double-stranded regions (PubMed:22055184). Also involved in activation of the ribosome quality control (RQC) pathway, a pathway that degrades nascent peptide chains during problematic translation (PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). Drives the splitting of stalled ribosomes that are ubiquitinated in a ZNF598-dependent manner, as part of the ribosome quality control trigger (RQT) complex (PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation (PubMed:12077347)","subcellular_location":"Nucleus; Nucleus speckle; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q8N3C0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ASCC3","classification":"Not Classified","n_dependent_lines":501,"n_total_lines":1208,"dependency_fraction":0.4147350993377483},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"EIF3G","stoichiometry":4.0},{"gene":"CAPRIN1","stoichiometry":0.2},{"gene":"DDX6","stoichiometry":0.2},{"gene":"EIF3B","stoichiometry":0.2},{"gene":"GSPT1","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"NPM3","stoichiometry":0.2},{"gene":"PSPC1","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"RBBP4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ASCC3","total_profiled":1310},"omim":[{"mim_id":"620700","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 81; MRT81","url":"https://www.omim.org/entry/620700"},{"mim_id":"614217","title":"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 3; ASCC3","url":"https://www.omim.org/entry/614217"},{"mim_id":"614216","title":"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 2; ASCC2","url":"https://www.omim.org/entry/614216"},{"mim_id":"614215","title":"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 1; ASCC1","url":"https://www.omim.org/entry/614215"},{"mim_id":"604501","title":"THYROID HORMONE RECEPTOR INTERACTOR 4; TRIP4","url":"https://www.omim.org/entry/604501"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ASCC3"},"hgnc":{"alias_symbol":["RNAH","ASC1p200","dJ121G13.4","dJ467N11.1"],"prev_symbol":["HELIC1"]},"alphafold":{"accession":"Q8N3C0","domains":[{"cath_id":"-","chopping":"50-142","consensus_level":"high","plddt":79.0899,"start":50,"end":142},{"cath_id":"-","chopping":"246-292","consensus_level":"medium","plddt":81.0232,"start":246,"end":292},{"cath_id":"3.40.50.300","chopping":"461-677","consensus_level":"high","plddt":85.1906,"start":461,"end":677},{"cath_id":"3.40.50.300","chopping":"686-873","consensus_level":"high","plddt":82.7526,"start":686,"end":873},{"cath_id":"2.60.40.150","chopping":"1182-1291","consensus_level":"medium","plddt":86.8013,"start":1182,"end":1291},{"cath_id":"3.40.50.300","chopping":"1297-1512","consensus_level":"medium","plddt":87.19,"start":1297,"end":1512},{"cath_id":"3.40.50.300","chopping":"1523-1718","consensus_level":"medium","plddt":84.1331,"start":1523,"end":1718},{"cath_id":"1.10.3380.10","chopping":"1837-1959","consensus_level":"medium","plddt":88.6012,"start":1837,"end":1959},{"cath_id":"2.60.40.150","chopping":"2035-2199","consensus_level":"high","plddt":74.7278,"start":2035,"end":2199},{"cath_id":"1.10.150","chopping":"1960-1980_1993-2033","consensus_level":"medium","plddt":80.9219,"start":1960,"end":2033}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N3C0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N3C0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N3C0-F1-predicted_aligned_error_v6.png","plddt_mean":79.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ASCC3","jax_strain_url":"https://www.jax.org/strain/search?query=ASCC3"},"sequence":{"accession":"Q8N3C0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N3C0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N3C0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N3C0"}},"corpus_meta":[{"pmid":"22055184","id":"PMC_22055184","title":"DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22055184","citation_count":173,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38148115","id":"PMC_38148115","title":"ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38148115","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33139697","id":"PMC_33139697","title":"The interaction of DNA repair factors ASCC2 and ASCC3 is affected by somatic cancer mutations.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33139697","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34217309","id":"PMC_34217309","title":"ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34217309","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3951991","id":"PMC_3951991","title":"Molecular cloning and in vitro transcription of rat 4.5S RNAH genes.","date":"1986","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/3951991","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35047834","id":"PMC_35047834","title":"Discovery of a neuromuscular syndrome caused by biallelic variants in ASCC3.","date":"2021","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/35047834","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17971306","id":"PMC_17971306","title":"Mouse nucleolin binds to 4.5S RNAh, a small noncoding RNA.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17971306","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26536629","id":"PMC_26536629","title":"Correlations between ASCC3 Gene Polymorphisms and Chronic Hepatitis B in a Chinese Han Population.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26536629","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40881169","id":"PMC_40881169","title":"Integrative multi-omics analysis and machine learning reveal the unique role of ASCC3 in combination with various immune-related genes in rectal adenocarcinoma.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40881169","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41061044","id":"PMC_41061044","title":"CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice.","date":"2025","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41061044","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41785087","id":"PMC_41785087","title":"Ski2-like helicase ASCC3 unwinds DNA upon fork stalling to control replication stress responses.","date":"2026","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41785087","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40777259","id":"PMC_40777259","title":"The Ski2 helicase ASCC3 unwinds DNA upon fork stalling to control replication stress responses.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40777259","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.17.660051","title":"Expanded gene targeting in RNA hacking with G-tract-supply Staple oligomer","date":"2025-06-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.17.660051","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.28.655095","title":"Aptamer-Enabled Discovery and Clinical Analysis of Exosomal Surface Biomarkers in Hepatocellular Carcinoma","date":"2025-05-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.28.655095","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.09.01.610654","title":"Sense codon-misassociated eRF1 elicits ribosome stalling and induction of quality control","date":"2024-09-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.01.610654","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25231870","id":"PMC_25231870","title":"Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25231870","citation_count":445,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32838362","id":"PMC_32838362","title":"Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.","date":"2020","source":"Med (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32838362","citation_count":291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11256614","id":"PMC_11256614","title":"Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing.","date":"2000","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11256614","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28757607","id":"PMC_28757607","title":"Ubiquitination of stalled ribosome triggers ribosome-associated quality control.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28757607","citation_count":260,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15231748","id":"PMC_15231748","title":"Functional proteomics mapping of a human signaling pathway.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15231748","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25578875","id":"PMC_25578875","title":"Structure and assembly pathway of the ribosome quality control complex.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25578875","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23022380","id":"PMC_23022380","title":"NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23022380","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8651,"output_tokens":2017,"usd":0.028104},"stage2":{"model":"claude-opus-4-6","input_tokens":5270,"output_tokens":2437,"usd":0.130912},"total_usd":0.347478,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":20911,"output_tokens":2624,"usd":0.051047},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6142,"output_tokens":2436,"usd":0.137415}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"ASCC3 encodes a 3'-5' DNA helicase that unwinds DNA to generate single-stranded DNA substrate upon which ALKBH3 preferentially performs dealkylation of N-alkylated nucleotides (3-methylcytosine). ASCC3 was purified as part of the ALKBH3-ASCC complex, and its helicase activity is required for alkylation damage resistance.\",\n      \"method\": \"Complex purification, in vitro helicase assay, siRNA knockdown with alkylation sensitivity readout, pH2A.X/53BP1 foci formation, 3-methylcytosine quantification\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted helicase activity, functional epistasis with ALKBH3, multiple orthogonal methods, highly cited foundational paper\",\n      \"pmids\": [\"22055184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ASCC3 interacts directly with ASCC2 through a central helical domain and terminal extended arms that clasp the compact ASCC2 unit. This interface is evolutionarily conserved and somatic cancer mutations at these interfaces reduce ASCC2-ASCC3 binding affinity. ASCC3 helicase organization and regulation is similar to the spliceosomal RNA helicase Brr2.\",\n      \"method\": \"Crystal structure of ASCC2-ASCC3 interacting regions, mutagenesis, quantitative binding assays, cancer mutation mapping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis and quantitative affinity measurements, multiple orthogonal methods\",\n      \"pmids\": [\"33139697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ASCC3 promotes P-body formation after alkylation damage and is required for selective clearance of chemically induced 1-methyladenosine (m1A) and 3-methylcytosine (m3C) from mRNA. ASCC3-deficient cells show delayed removal of these aberrant mRNA methylbases and impaired MMS-induced P-body formation, consistent with ASCC3-mediated disassembly of collided ribosomes enabling ALKBH3 access to damaged mRNA.\",\n      \"method\": \"Quantitative mass spectrometry (SILAC), ASCC3 knockout/knockdown, P-body imaging, mRNA methylbase quantification\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined molecular phenotype and multiple orthogonal methods, single lab\",\n      \"pmids\": [\"34217309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ASCC3 stabilizes STAT3 signaling by recruiting CAND1, which inhibits ubiquitin-mediated proteasomal degradation of STAT3, thereby impairing the type I interferon response in NSCLC tumor cells and promoting immunosuppression.\",\n      \"method\": \"Immunoprecipitation, mass spectrometry, immunofluorescence, RNA sequencing, flow cytometry, in vivo mouse models\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP/MS identifying CAND1 as recruited partner, functional rescue experiments, moderate evidence from single lab\",\n      \"pmids\": [\"38148115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ASCC3 is recruited to stalled replication forks by its binding partner ASCC2, which itself requires ubiquitin-binding activity and polyubiquitylation of PCNA at K164 (catalyzed by SHPRH, HLTF, and RFWD3) for fork recruitment. Upon replication stress, ASCC3 unwinds DNA to remodel gap-containing fork substrates, promoting fork reversal, stimulating SMARCAL1 recruitment, restraining fork progression, and enabling RPA accumulation on ssDNA for efficient ATR activation. ASCC3 also antagonizes RAD51-mediated recombination to prevent chromosome breaks/gaps and mis-segregation.\",\n      \"method\": \"In vitro DNA unwinding assay on fork substrates, epistasis with SHPRH/HLTF/RFWD3/BRCA1/BRCA2, Co-IP, iPOND/proximity ligation, chromosome break analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of fork substrate unwinding combined with genetic epistasis and multiple cellular phenotypes, published peer-reviewed\",\n      \"pmids\": [\"41785087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FMRP recruits ASCC3 to collided ribosomes as part of ribosome-associated quality control (RQC). In FXS patient cells and Fmr1 KO mice, ASCC3 abundance is reduced. Disease-associated ASCC3 variants that perturb ASCC3-FMRP interaction are defective in ribosome association and handling of collided ribosomes. ASCC3 overexpression in fetal Fmr1 KO mouse brains promoted neuronal migration, and CRISPR-mediated ASCC3 activation ameliorated synaptic defects and behavioral deficits in adult Fmr1 KO mice.\",\n      \"method\": \"Co-IP (FMRP-ASCC3), ribosome fractionation, ASCC3 variant functional analysis, Fmr1 KO mouse model, AAV-CRISPR activation, behavioral assays\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, ribosome association assays, variant functional dissection, and in vivo rescue with multiple phenotypic readouts\",\n      \"pmids\": [\"41061044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ASCC3, together with 4EHP, suppresses ribosome collisions at UUA sense codons misrecognized by eRF1. Depletion of ASCC3 leads to failure of ribosome collision repression and triggers a stress response including induction of ATF3.\",\n      \"method\": \"Disome-Seq with ASCC3 depletion, eRF1-selective Monosome-Seq, stress response gene expression analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ribosome profiling with KD and defined molecular phenotype, preprint single lab\",\n      \"pmids\": [\"bio_10.1101_2024.09.01.610654\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ASCC3 is a dual-cassette Ski2-like 3'-5' DNA/RNA helicase that functions as the catalytic engine of the ASCC complex: it unwinds nucleic acids to generate ssDNA for ALKBH3-mediated dealkylation repair of N-methylated bases in DNA and mRNA, remodels stalled replication forks (promoting fork reversal and ATR activation via RPA loading), disassembles collided ribosomes as an early ribosome-associated quality control factor (in concert with FMRP), and can modulate STAT3 stability by recruiting CAND1 to inhibit ubiquitin-mediated degradation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"ASCC3 is the largest subunit of the Activating Signal Cointegrator Complex (ASCC) and encodes a 3'-5' DNA helicase whose unwinding activity generates single-stranded DNA upon which the demethylase ALKBH3 preferentially acts to repair N-alkylated nucleotides (3-methylcytosine and 1-methyladenine). Loss of ASCC3 leads to increased 3-methylcytosine, reduced cancer cell proliferation, and formation of pH2A.X and 53BP1 foci, indicating a role in maintaining genomic integrity.\",\n      \"method\": \"Affinity purification of ALKBH3 complex, in vitro helicase assay, siRNA knockdown with alkylation damage resistance assays, immunofluorescence for DNA damage markers\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro helicase activity demonstrated, complex purified, multiple functional readouts with KD, replicated across cell lines\",\n      \"pmids\": [\"22055184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The ASCC3 subunit functions as a dual-cassette Ski2-like nucleic acid helicase. The ASCC2-ASCC3 interaction interface was structurally characterized: the ASCC3 fragment comprises a central helical domain and terminal extended arms that clasp the compact ASCC2 unit. This interface is evolutionarily conserved and harbors numerous somatic cancer mutation sites; cancer-associated mutations reduce ASCC2-ASCC3 binding affinity. ASCC3 domain organization is similar to that of the spliceosomal RNA helicase Brr2.\",\n      \"method\": \"X-ray crystallography of ASCC2-ASCC3 interacting regions, binding affinity quantification, mutational analysis of cancer variants\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional mutagenesis and quantitative binding measurements in a single study\",\n      \"pmids\": [\"33139697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ASCC3 promotes disassembly of collided ribosomes as part of the ribosome quality control (RQC) trigger complex. ASCC3-deficient cells display delayed removal of MMS-induced 1-methyladenosine (m1A) and 3-methylcytosine (m3C) from mRNA and impaired formation of MMS-induced P-bodies. ASCC3 also shows increased mRNA binding after MMS treatment, and its role in ribosome disassembly is proposed to allow access of ALKBH3 for demethylation of aberrant mRNA methylbases.\",\n      \"method\": \"Quantitative SILAC mass spectrometry of mRNA-binding proteome, ASCC3 knockdown with quantitative measurement of mRNA methylbases, P-body formation assay by immunofluorescence\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a single study; functional phenotype in KD cells with quantitative readouts\",\n      \"pmids\": [\"34217309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Biallelic loss-of-function variants in ASCC3 cause a neuromuscular syndrome in humans ranging from severe developmental delay to muscle fatigue, establishing ASCC3 as a disease gene. Genotype-phenotype correlation was observed: homozygous missense variants cause milder phenotypes, while compound heterozygotes for missense and presumed LOF variants are more severely affected, and no biallelic presumed LOF individuals are found, suggesting this genotype may be lethal.\",\n      \"method\": \"Exome/genome sequencing of seven unrelated families, clinical phenotyping, gnomAD population analysis\",\n      \"journal\": \"HGG advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetic evidence across multiple unrelated families with genotype-phenotype correlation, though no in vitro mechanistic follow-up\",\n      \"pmids\": [\"35047834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ASCC3 stabilizes STAT3 signaling by recruiting CAND1, which inhibits ubiquitin-mediated proteasomal degradation of STAT3, thereby impairing the type I interferon response in non-small cell lung cancer cells and promoting immunosuppression. ASCC3 overexpression decreases CD8+ T cells, NK cells and dendritic cells and increases regulatory T cells in the tumor microenvironment.\",\n      \"method\": \"Immunoprecipitation, mass spectrometry, RNA sequencing, immunofluorescence, flow cytometry, in vivo mouse tumor models with ASCC3 knockdown and anti-PD-1 combination\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP/MS identification of CAND1 interaction, functional KD with defined immune phenotype readouts in vitro and in vivo\",\n      \"pmids\": [\"38148115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ASCC3 is recruited to stalled replication forks by its binding partner ASCC2, whose fork recruitment requires ubiquitin-binding activity and polyubiquitylation of PCNA at K164 by E3 ligases SHPRH, HLTF, and RFWD3. Upon replication stress, ASCC3 helicase activity unwinds DNA at stalled forks, remodeling gap-containing fork substrates and promoting fork reversal. ASCC3 also interacts with RPA and stimulates RPA accumulation on ssDNA to promote ATR activation, antagonizes RAD51-mediated recombination, and prevents chromosome breaks/gaps and mis-segregation.\",\n      \"method\": \"In vitro DNA unwinding/fork remodeling assays, co-immunoprecipitation, iPOND (isolation of proteins on nascent DNA), genetic epistasis with SHPRH/HLTF/RFWD3/BRCA1/BRCA2, RPA accumulation assays, ATR activation assays, chromosome break quantification\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of fork remodeling activity, multiple orthogonal genetic and biochemical approaches, strong mechanistic dissection\",\n      \"pmids\": [\"41785087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FMRP (fragile X messenger ribonucleoprotein) regulates collided ribosomes by recruiting ASCC3 to collided ribosomes. Loss of FMRP reduces ASCC3 abundance. ASCC3 overexpression in fetal Fmr1 KO mouse brains promotes neuronal migration, and CRISPR-mediated activation of ASCC3 via AAV injection ameliorates synaptic defects, locomotor, cognitive, obsessive-compulsive-like, and social interaction deficits in Fmr1 KO mice. Disease-associated ASCC3 variants that disrupt ASCC3-FMRP interaction are also defective in ribosome association and handling of collided ribosomes.\",\n      \"method\": \"Co-immunoprecipitation of ASCC3-FMRP, ribosome association assays in cell lines and iPSC-derived neurons, Fmr1 KO mouse model with ASCC3 overexpression or CRISPRa-AAV, behavioral testing, mutagenesis of disease-associated variants\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (Co-IP, ribosome assays, mutagenesis, in vivo AAV rescue in mouse model) with defined functional phenotypes\",\n      \"pmids\": [\"41061044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ASCC3, as a key factor for ribosome rescue, suppresses ribosome collisions that arise constitutively at UUA sense codons due to transient eRF1 misreading. Depletion of ASCC3 leads to accumulation of disomes at UUA codons and triggers stress responses including induction of the stress transcription factor ATF3, indicating ASCC3 is required for translation homeostasis.\",\n      \"method\": \"Disome-Seq (ribosome profiling of collided ribosomes) with ASCC3 depletion, stress response gene expression analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ribosome profiling with ASCC3 KD provides direct mechanistic evidence; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2024.09.01.610654\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ASCC3 is a multifunctional Ski2-like 3'-5' DNA/RNA helicase that (1) generates single-stranded DNA to enable ALKBH3-mediated repair of N-alkylated nucleotides in a complex with ASCC2 (which anchors it to stalled replication forks via PCNA polyubiquitylation), (2) promotes fork reversal, RPA loading, and ATR activation at stalled replication forks while antagonizing RAD51 recombination, (3) disassembles collided ribosomes as part of the ribosome-associated quality control trigger complex to allow ALKBH3-mediated mRNA demethylation and to maintain translation homeostasis, (4) is recruited to collided ribosomes by FMRP to regulate neurodevelopmental translation, and (5) stabilizes STAT3 via CAND1 recruitment to inhibit its ubiquitin-mediated degradation in cancer cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ASCC3 is a dual-cassette Ski2-like 3′-to-5′ helicase that serves as the catalytic engine of the ASCC complex, coupling nucleic-acid unwinding to alkylation damage repair, replication fork remodeling, and ribosome-associated quality control. ASCC3 unwinds duplex DNA to generate single-stranded substrate for ALKBH3-mediated dealkylation of N-methylated bases in both DNA and mRNA, and its loss causes alkylation sensitivity, impaired clearance of m1A/m3C from mRNA, and defective P-body formation [PMID:22055184, PMID:34217309]. At stalled replication forks, ASCC3 is recruited via ASCC2-dependent recognition of polyubiquitylated PCNA, where it remodels gap-containing fork structures to promote fork reversal, SMARCAL1 recruitment, RPA-dependent ATR activation, and suppression of RAD51-mediated recombination that would otherwise cause chromosome breaks [PMID:41785087]. ASCC3 also functions as an early ribosome-associated quality-control factor recruited to collided ribosomes by FMRP; disease-associated ASCC3 variants disrupt this interaction, and CRISPR-mediated ASCC3 activation rescues synaptic and behavioral deficits in Fmr1-knockout mice, linking ASCC3 dysfunction to Fragile X syndrome pathophysiology [PMID:41061044].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"The fundamental question of how alkylated bases in DNA are made accessible to the repair demethylase ALKBH3 was answered: ASCC3 was identified as a 3′-to-5′ DNA helicase that unwinds duplex DNA to generate single-stranded substrate for ALKBH3, establishing the ASCC complex as the catalytic platform for dealkylation repair.\",\n      \"evidence\": \"Complex purification, in vitro helicase assay, siRNA knockdown with alkylation sensitivity, γH2A.X/53BP1 foci, 3-methylcytosine quantification in human cells\",\n      \"pmids\": [\"22055184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural model of ASCC3 helicase domains or mechanism of strand separation\",\n        \"How ASCC3 is recruited to sites of alkylation damage was unknown\",\n        \"Whether ASCC3 acts on RNA substrates was not tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How ASCC3 is assembled into the ASCC complex was resolved structurally: crystal structures revealed that ASCC2 clasps ASCC3 through a conserved helical domain and extended arms, and that somatic cancer mutations at this interface reduce binding, providing a structural basis for complex integrity and disease relevance.\",\n      \"evidence\": \"Crystal structure of ASCC2–ASCC3 interface, mutagenesis, quantitative binding assays, cancer mutation mapping\",\n      \"pmids\": [\"33139697\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure of full-length ASCC3 or the complete ASCC holo-complex was not determined\",\n        \"Whether ASCC2–ASCC3 interaction is regulated by post-translational modifications remains unknown\",\n        \"Functional consequence of cancer-associated interface mutations on repair activity not tested in cells\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The scope of ASCC3 function was extended from DNA to RNA: ASCC3 was shown to be required for selective clearance of alkylation-induced m1A and m3C from mRNA and for P-body formation after damage, establishing a role in mRNA quality control downstream of collided ribosomes.\",\n      \"evidence\": \"SILAC mass spectrometry, ASCC3 KO/KD, P-body imaging, mRNA methylbase quantification in human cells\",\n      \"pmids\": [\"34217309\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct helicase activity on RNA substrates not reconstituted in vitro\",\n        \"Whether ASCC3-dependent P-body formation requires ALKBH3 was not dissected\",\n        \"Mechanism connecting ribosome disassembly to mRNA dealkylation not resolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A non-canonical signaling role was uncovered: ASCC3 stabilizes STAT3 by recruiting CAND1 to inhibit ubiquitin-mediated degradation, thereby suppressing the type I interferon response in NSCLC and promoting tumor immune evasion.\",\n      \"evidence\": \"Co-IP/mass spectrometry, immunofluorescence, RNA-seq, flow cytometry, in vivo mouse tumor models\",\n      \"pmids\": [\"38148115\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The ASCC3–CAND1 interaction has not been validated by reciprocal endogenous pull-down or structural analysis\",\n        \"Whether this function requires ASCC3 helicase activity is unknown\",\n        \"Generalizability beyond NSCLC not established\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"ASCC3's role at replication forks was defined: ASCC2-dependent recruitment to polyubiquitylated PCNA enables ASCC3 to unwind gap-containing fork substrates, driving fork reversal, SMARCAL1 recruitment, RPA-loaded ATR activation, and suppression of deleterious RAD51-mediated recombination.\",\n      \"evidence\": \"In vitro fork-substrate unwinding assay, epistasis with SHPRH/HLTF/RFWD3/BRCA1/BRCA2, iPOND, proximity ligation, chromosome break analysis in human cells\",\n      \"pmids\": [\"41785087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How ASCC3 helicase activity is specifically activated at forks versus alkylation sites is unclear\",\n        \"Whether ASCC3 fork remodeling is relevant to ICL repair or other replication barriers not tested\",\n        \"Structural basis of ASCC3 on fork DNA not resolved\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"ASCC3 was established as an early ribosome-associated quality-control factor recruited to collided ribosomes by FMRP; disease-associated ASCC3 variants lose ribosome association, and ASCC3 activation rescues neuronal and behavioral phenotypes in Fmr1-KO mice, directly linking ASCC3 to Fragile X syndrome pathology.\",\n      \"evidence\": \"Reciprocal Co-IP (FMRP–ASCC3), ribosome fractionation, variant functional analysis, Fmr1-KO mouse AAV-CRISPR activation, behavioral assays\",\n      \"pmids\": [\"41061044\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ASCC3 helicase activity is required for ribosome splitting at collision sites is not shown\",\n        \"Direct structural or biochemical reconstitution of ASCC3 on collided ribosomes is lacking\",\n        \"How FMRP loss quantitatively reduces ASCC3 protein abundance is mechanistically unexplained\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include whether ASCC3 has bona fide RNA helicase activity, how its helicase is differentially activated across its DNA-repair, fork-remodeling, and RQC functions, and whether its non-canonical STAT3-stabilizing role is helicase-dependent or represents a scaffold function.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No in vitro RNA unwinding activity has been demonstrated for ASCC3\",\n        \"No full-length cryo-EM or crystal structure of ASCC3 is available\",\n        \"Regulatory mechanisms (e.g. PTMs, cofactor switching) that direct ASCC3 to different substrates remain uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 5, 6]}\n    ],\n    \"complexes\": [\n      \"ASCC complex (ALKBH3-ASCC)\"\n    ],\n    \"partners\": [\n      \"ASCC2\",\n      \"ALKBH3\",\n      \"FMRP\",\n      \"CAND1\",\n      \"SMARCAL1\",\n      \"PCNA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ASCC3 is a Ski2-like 3′-to-5′ DNA/RNA helicase that serves as the catalytic engine of the Activating Signal Cointegrator Complex, coupling nucleic acid unwinding to alkylation damage repair, replication fork protection, and ribosome-associated quality control. As the largest ASCC subunit, ASCC3 generates single-stranded DNA substrates for the demethylase ALKBH3 to remove 1-methyladenine and 3-methylcytosine lesions, and it is recruited to stalled replication forks via ASCC2-mediated recognition of polyubiquitylated PCNA, where its helicase activity promotes fork reversal, RPA loading, ATR activation, and suppression of RAD51-dependent recombination [PMID:22055184, PMID:41785087]. ASCC3 also disassembles collided ribosomes—recruited by FMRP—to maintain translational homeostasis and permit ALKBH3-mediated mRNA demethylation; loss of this function triggers stress responses and ribosome collision accumulation at UUA sense codons [PMID:34217309, PMID:41061044]. Biallelic loss-of-function variants in ASCC3 cause a human neuromuscular syndrome with developmental delay, and disease-associated missense variants disrupt FMRP interaction and ribosome association [PMID:35047834, PMID:41061044].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that ASCC3 is a 3′-to-5′ DNA helicase within the ALKBH3 complex resolved how single-stranded DNA is generated for alkylation damage repair, establishing ASCC3's first known enzymatic activity and linking it to genomic integrity.\",\n      \"evidence\": \"Affinity purification of ALKBH3 complex, in vitro helicase assay, siRNA knockdown with alkylation sensitivity and DNA damage marker readouts in human cancer cell lines\",\n      \"pmids\": [\"22055184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of helicase activity and substrate specificity not resolved\",\n        \"How ASCC3 is recruited to sites of alkylation damage was unknown\",\n        \"Whether ASCC3 acts on RNA substrates in vivo was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Structural determination of the ASCC2-ASCC3 interface revealed a conserved dual-cassette Ski2-like helicase architecture and showed that somatic cancer mutations cluster at the binding surface, explaining how the complex is assembled and why certain cancer variants are loss-of-function.\",\n      \"evidence\": \"X-ray crystallography of ASCC2-ASCC3 interacting regions, quantitative binding assays, cancer variant mutagenesis\",\n      \"pmids\": [\"33139697\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full-length ASCC3 structure and mechanism of helicase processivity not determined\",\n        \"How ASCC2-ASCC3 disruption by cancer mutations affects repair in cells was not tested\",\n        \"No structure of ASCC3 bound to nucleic acid substrates\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Two parallel advances linked ASCC3 to ribosome quality control and human disease: ASCC3 was shown to disassemble collided ribosomes to allow ALKBH3-mediated mRNA demethylation, while independent genetic studies identified biallelic ASCC3 variants as causative for a neuromuscular syndrome with genotype-severity correlation.\",\n      \"evidence\": \"SILAC proteomics of mRNA-binding proteins after MMS, quantitative mRNA methylbase measurement, P-body assays (ribosome role); exome/genome sequencing across seven unrelated families with clinical phenotyping (disease genetics)\",\n      \"pmids\": [\"34217309\", \"35047834\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which ASCC3 disassembles collided ribosomes was not reconstituted in vitro\",\n        \"No functional assay linking patient variants to helicase activity or ribosome disassembly defects at this stage\",\n        \"How mRNA demethylation defects contribute to neuromuscular pathology was unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"An unexpected signaling role was uncovered: ASCC3 stabilizes STAT3 by recruiting CAND1 to inhibit ubiquitin-mediated STAT3 degradation, suppressing type I interferon signaling and promoting immunosuppression in non-small cell lung cancer.\",\n      \"evidence\": \"Reciprocal Co-IP/mass spectrometry for CAND1 interaction, RNA-seq, flow cytometry for immune cell populations, in vivo mouse tumor models with ASCC3 knockdown and anti-PD-1 combination\",\n      \"pmids\": [\"38148115\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether STAT3 stabilization depends on ASCC3 helicase activity or is independent was not tested\",\n        \"Generalizability to other cancer types not established\",\n        \"Mechanism by which ASCC3-CAND1 interaction blocks STAT3 ubiquitylation is unclear\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies completed the mechanistic picture at replication forks and collided ribosomes: ASCC3 was shown to be recruited to stalled forks via ASCC2/polyubiquitylated-PCNA to drive fork reversal, RPA loading, and ATR activation while antagonizing RAD51 recombination; separately, FMRP was identified as the factor that recruits ASCC3 to collided ribosomes, with disease-associated ASCC3 variants disrupting FMRP binding and ribosome association, and ASCC3 restoration rescuing Fragile X phenotypes in Fmr1 KO mice.\",\n      \"evidence\": \"In vitro fork remodeling and DNA unwinding, iPOND, genetic epistasis with SHPRH/HLTF/RFWD3/BRCA pathway (fork role); Co-IP of ASCC3-FMRP, ribosome profiling in iPSC-neurons, CRISPRa-AAV rescue of behavioral deficits in Fmr1 KO mice, disease variant mutagenesis (ribosome role)\",\n      \"pmids\": [\"41785087\", \"41061044\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the fork remodeling and ribosome QC functions are coordinated or independently regulated is unknown\",\n        \"Structural basis of ASCC3 engagement with collided ribosomes or reversed forks not resolved\",\n        \"Whether ASCC3-mediated fork reversal operates in normal replication or only under replication stress is unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include how ASCC3's helicase activity is regulated to switch between DNA repair, replication fork protection, and ribosome quality control functions, whether the STAT3-stabilizing role depends on the same protein interfaces as its canonical repair/QC roles, and what structural basis underlies ASCC3's engagement with diverse nucleoprotein substrates.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No full-length structure of ASCC3 or ASCC3-substrate complex available\",\n        \"Regulatory logic governing substrate-specific engagement (DNA forks vs. collided ribosomes) not defined\",\n        \"Contribution of each ASCC3 function to the human neuromuscular phenotype remains unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [2, 6, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 6, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"ASCC (Activating Signal Cointegrator Complex)\",\n      \"RQC trigger complex (ribosome quality control)\"\n    ],\n    \"partners\": [\n      \"ASCC2\",\n      \"ALKBH3\",\n      \"FMRP\",\n      \"RPA\",\n      \"CAND1\",\n      \"STAT3\",\n      \"PCNA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}